BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 6130805)

  • 1. Antisickling effects of membrane-interacting compounds.
    Ohnishi ST
    Blood Cells; 1982; 8(2):337-43. PubMed ID: 6130805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of pH on the rheologic and antisickling effects of dimethyl adipimidate.
    Pennathur-Das R; Lande WM; Mentzer WC; Mohandas N; Preisler H; Kleman KM; Heath RH; Lubin BH
    J Lab Clin Med; 1984 Nov; 104(5):718-29. PubMed ID: 6491469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viscosity and filtrability measurements of sickle-cell suspensions in the development of anti-sickling drugs.
    Ohnishi ST
    Blood Cells; 1982; 8(1):79-87. PubMed ID: 7115980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cetiedil on erythrocyte sickling: new type of antisickling agent that may affect erythrocyte membranes.
    Asakura T; Ohnishi ST; Adachi K; Ozguc M; Hashimoto K; Singer M; Russell MO; Schwartz E
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2955-9. PubMed ID: 6930678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sulfhydryl reagents on the anti-sickling activity of some membrane-interacting compounds.
    Sato T; Ohnishi ST
    Biochim Biophys Acta; 1983 Jan; 727(1):196-200. PubMed ID: 6824650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologic and rheologic effects of the antisickling agent ethacrynic acid and its N-butylated derivative on normal and sickle erythrocytes.
    Orringer EP; Blythe DS; Whitney JA; Brockenbrough S; Abraham DJ
    Am J Hematol; 1992 Jan; 39(1):39-44. PubMed ID: 1536139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of erythrocyte sickling by thiol reagents.
    Garel MC; Domenget C; Galacteros F; Martin-Caburi J; Beuzard Y
    Mol Pharmacol; 1984 Nov; 26(3):559-65. PubMed ID: 6493211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of cetiedil on red cell membrane permeability.
    Schmidt WF; Asakura T; Schwartz E
    Blood Cells; 1982; 8(2):289-98. PubMed ID: 7159753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative studies of phenothiazine derivatives for their effects on swelling of normal and sickle erythrocytes.
    Thompson AA; Cornelius AS; Asakura T; Horiuchi K
    Gen Pharmacol; 1993 Jul; 24(4):999-1006. PubMed ID: 7901117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of action of two anti-sickling agents: sodium cyanate and glyceraldehyde.
    Manning JM; Acharya AS
    Am J Pediatr Hematol Oncol; 1984; 6(1):51-4. PubMed ID: 6711764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bepridil as an antisickling agent: membrane internalization and cell rigidity.
    Johnson RM; Acquaye C; Féo C; Sarnaik S
    Am J Hematol; 1994 Aug; 46(4):310-8. PubMed ID: 8037182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vitro method for screening compounds for the effect on the rate of sickling of erythrocytes.
    Mackenzie RD; Gleason EM; Schatzman GL; Cawein MJ
    J Int Med Res; 1976; 4(6):375-81. PubMed ID: 1027632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cetiedil on monovalent cation permeability in the erythrocyte: an explanation for the efficacy of cetiedil in the treatment of sickle cell anemia.
    Berkowitz LR; Orringer EP
    Blood Cells; 1982; 8(2):283-8. PubMed ID: 7159752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antisickling role of uric acid in sickle cell disease.
    Ekeke GI; Nduka N
    Trop Geogr Med; 1987 Apr; 39(2):152-6. PubMed ID: 3629708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of erythrocyte calcium transport by cetiedil.
    Levine SN; Berkowitz LR; Orringer EP
    Pharmacology; 1988; 36(1):44-51. PubMed ID: 2829242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red cell membrane abnormalities in sickle cell anemia.
    Bookchin RM; Lew VL
    Prog Hematol; 1983; 13():1-23. PubMed ID: 6322226
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia.
    Covas DT; de Lucena Angulo I; Vianna Bonini Palma P; Zago MA
    Haematologica; 2004 Mar; 89(3):273-80. PubMed ID: 15020264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of methyl acetimidate as an extracorporeal antisickling agent.
    Chao TL; Berenfeld MR; Gabuzda TG
    Am J Pediatr Hematol Oncol; 1984; 6(1):55-8. PubMed ID: 6711765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of glyceraldehyde on the structural and functional properties of sickle erythrocytes.
    Nigen AM; Manning JM
    J Clin Invest; 1978 Jan; 61(1):11-9. PubMed ID: 618907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of sickling.
    Mentzer WC
    Am J Pediatr Hematol Oncol; 1982; 4(3):320-7. PubMed ID: 7149171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.